Price Jackson
Price Jackson
Peter MacCallum Cancer Centre
Verified email at
Cited by
Cited by
Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy
WN Rahman, N Bishara, T Ackerly, CF He, P Jackson, C Wong, ...
Nanomedicine: Nanotechnology, Biology and Medicine 5 (2), 136-142, 2009
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents
PA Jackson, WNWA Rahman, CJ Wong, T Ackerly, M Geso
European journal of radiology 75 (1), 104-109, 2010
Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes
J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ...
Journal of Nuclear Medicine 60 (4), 517-523, 2019
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging
PA Jackson, JM Beauregard, MS Hofman, T Kron, A Hogg, RJ Hicks
Medical physics 40 (11), 112503, 2013
Long-term follow-up and outcomes of retreatment in an expanded 50-patient single-center phase II prospective trial of 177Lu-PSMA-617 theranostics in metastatic castration …
J Violet, S Sandhu, A Iravani, J Ferdinandus, SP Thang, G Kong, ...
Journal of Nuclear Medicine 61 (6), 857-865, 2020
Evaluation of the effects of gold nanoparticle shape and size on contrast enhancement in radiological imaging
P Jackson, S Periasamy, V Bansal, M Geso
Australasian physical & engineering sciences in medicine 34 (2), 243, 2011
Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy
P Jackson, N Hardcastle, N Dawe, T Kron, MS Hofman, RJ Hicks
Frontiers in oncology 8, 215, 2018
Analysis of 177Lu-DOTA-octreotate therapy–induced DNA damage in peripheral blood lymphocytes of patients with neuroendocrine tumors
D Denoyer, P Lobachevsky, P Jackson, M Thompson, OA Martin, ...
Journal of Nuclear Medicine 56 (4), 505-511, 2015
Cold kit for prostate-specific membrane antigen (PSMA) PET imaging: phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
MS Hofman, P Eu, P Jackson, E Hong, D Binns, A Iravani, D Murphy, ...
Journal of Nuclear Medicine 59 (4), 625-631, 2018
Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship
S Siva, P Jackson, T Kron, M Bressel, E Lau, M Hofman, M Shaw, ...
Radiotherapy and Oncology 118 (3), 540-546, 2016
Role of epidermal growth factor and transforming growth factor α in the developing stomach: These data were presented at the spring meeting of the British Society of …
EJ Kelly, SJ Newell, KG Brownlee, SM Farmery, C Cullinane, WA Reid, ...
Archives of Disease in Childhood-Fetal and Neonatal Edition 76 (3), F158-F162, 1997
Rapid blood clearance and lack of long-term renal toxicity of 177 Lu-DOTATATE enables shortening of renoprotective amino acid infusion
R Kashyap, P Jackson, MS Hofman, P Eu, JM Beauregard, D Zannino, ...
European journal of nuclear medicine and molecular imaging 40 (12), 1853-1860, 2013
timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99m Tc-DMSA SPECT/CT
P Jackson, F Foroudi, D Pham, MS Hofman, N Hardcastle, J Callahan, ...
Radiation Oncology 9 (1), 1-4, 2014
64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor …
RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman, DA Pattison, ...
Journal of Nuclear Medicine 60 (6), 777-785, 2019
Accuracy and utility of deformable image registration in 68Ga 4D PET/CT assessment of pulmonary perfusion changes during and after lung radiation therapy
N Hardcastle, MS Hofman, RJ Hicks, J Callahan, T Kron, MP MacManus, ...
International Journal of Radiation Oncology* Biology* Physics 93 (1), 196-204, 2015
Cold Kit PSMA PET Imaging: Phase I study of 68Ga-THP-PSMA PET/CT in patients with prostate cancer
MS Hofman, P Eu, P Jackson, E Hong, D Binns, A Iravani, D Murphy, ...
Journal of Nuclear Medicine, jnumed. 117.199554, 2017
Radiation dosimetry in 177Lu-PSMA-617 therapy using a single posttreatment SPECT/CT scan: a novel methodology to generate time-and tissue-specific dose factors
PA Jackson, MS Hofman, RJ Hicks, M Scalzo, J Violet
Journal of Nuclear Medicine 61 (7), 1030-1036, 2020
Voxel‐wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated …
HM Reynolds, S Williams, P Jackson, C Mitchell, MS Hofman, RJ Hicks, ...
BJU international 123 (6), 1020-1030, 2019
High activity, pain reduction and low toxicity with Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): results of a phase II …
M Hofman, J Violet, S Sandhu, J Ferdinandus, SP Thang, A Iravani, ...
Journal of Nuclear Medicine 59 (supplement 1), 531-531, 2018
The system can't perform the operation now. Try again later.
Articles 1–20